At the time of writing, Repligen Corp [RGEN] stock is trading at $126.64, down -0.40%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 11.56% over the last week, with a monthly amount glided 5.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Barclays started tracking the stock with Overweight rating on June 24, 2025, and set its price target to $150. On April 29, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $160 on the stock. Evercore ISI started tracking the stock assigning a In-line rating and suggested a price target of $155 on March 18, 2025. TD Cowen initiated its recommendation with a Buy and recommended $200 as its price target on February 10, 2025. Canaccord Genuity started tracking with a Hold rating for this stock on December 17, 2024, and assigned it a price target of $165. In a note dated November 14, 2024, Wolfe Research initiated an Peer Perform rating.
For the past year, the stock price of Repligen Corp fluctuated between $102.96 and $182.52. Currently, Wall Street analysts expect the stock to reach $193.86 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $126.64 at the most recent close of the market. An investor can expect a potential return of 53.08% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
According to Repligen Corp [NASDAQ:RGEN], the company’s sales were 673.96M for trailing twelve months, which represents an 14.81% jump. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 125.09 points at the first support level, and at 123.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 127.52, and for the 2nd resistance point, it is at 128.41.
Ratios To Look Out For
It is important to note that Repligen Corp [NASDAQ:RGEN] has a current ratio of 8.59. In addition, the Quick Ratio stands at 7.32 and the Cash Ratio stands at 4.59. Considering the valuation of this stock, the price to sales ratio is 10.57, the price to book ratio is 3.46.
Transactions by insiders
Recent insider trading involved Madaus Martin D, Director, that happened on Aug 08 ’25 when 1800.0 shares were purchased. Director, Hunt Anthony completed a deal on May 15 ’25 to sell 26447.0 shares. Meanwhile, Director Hunt Anthony bought 26447.0 shares on May 15 ’25.
